These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 21424289)

  • 1. [Peritoneal carcinomatosis].
    Königsrainer I; Beckert S; Lehmann T; Ladurner R; Brücher B; Königsrainer A
    Chirurg; 2011 Apr; 82(4):375-80; quiz 381. PubMed ID: 21424289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Selection criteria for peritonectomy with hyperthermic intraoperative chemotherapy (HIPEC) in peritoneal carcinomatosis].
    Königsrainer I; Aschoff P; Zieker D; Beckert S; Glatzle J; Pfannenberg C; Miller S; Hartmann JT; Schroeder TH; Brücher BL; Königsrainer A
    Zentralbl Chir; 2008 Sep; 133(5):468-72. PubMed ID: 18924046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The techniques of peritonectomy and hyperthermic intraperitoneal chemotherapy].
    Lang SA; Glockzin G; Dahlke MH; Popp FC; Agha A; Schlitt HJ; Piso P
    Zentralbl Chir; 2009 Sep; 134(5):443-9. PubMed ID: 19492282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Peritoneal carcinomatosis of colorectal cancer: cytoreductive surgery and hyperthermic intraperitoneal chemotherapy].
    Königsrainer I; Beckert S; Brücher B; Zieker D; Königsrainer A
    Dtsch Med Wochenschr; 2011 Sep; 136(36):1811-4. PubMed ID: 21882140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the treatment of peritoneal carcinomatosis: initial experience in Oaxaca, Mexico.
    García-Matus R; Hernández-Hernández CA; Leyva-García O; Vásquez-Ciriaco S; Flores-Ayala G; Navarro-Hernández Q; Pérez-Bustamante G; Valencia-Mijares NM; Esquivel J
    Am Surg; 2012 Sep; 78(9):942-6. PubMed ID: 22964201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy with lobaplatin and docetaxel improves survival for patients with peritoneal carcinomatosis from abdominal and pelvic malignancies.
    Wu HT; Yang XJ; Huang CQ; Sun JH; Ji ZH; Peng KW; Zhang Q; Li Y
    World J Surg Oncol; 2016 Sep; 14(1):246. PubMed ID: 27633880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hyperthermic intraperitoneal chemotherapy at the primary gastrointestinal cancer operation].
    Degett TH; Pommergaard HC; Gögenur I
    Ugeskr Laeger; 2017 Mar; 179(12):. PubMed ID: 28330549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Surgical management of patients with peritoneal carcinomatosis of gastrointestinal origin].
    Iesalnieks I; Kullmann F; Dahlke M; Ghali N; Agha A; von Breitenbuch P; Schoelmerich J; Schlitt HJ; Piso P
    Z Gastroenterol; 2006 Dec; 44(12):1237-45. PubMed ID: 17163375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytoreductive surgery and perioperative intraperitoneal chemotherapy in patients with peritoneal carcinomatosis of colonic origin: outcomes after 7 years' experience of a new centre for peritoneal surface malignancies.
    Bretcha-Boix P; Farré-Alegre J; Sureda M; Dussan C; Pérez Ruixo JJ; Brugarolas Masllorens A
    Clin Transl Oncol; 2010 Jun; 12(6):437-42. PubMed ID: 20534399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peritoneal carcinomatosis of gastrointestinal tumors: where are we now?
    Terzi C; Arslan NC; Canda AE
    World J Gastroenterol; 2014 Oct; 20(39):14371-80. PubMed ID: 25339824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of peritoneal carcinomatosis from colonic cancer by cytoreduction, peritonectomy and hyperthermic intraperitoneal chemotherapy (HIPEC). Experience of ten years.
    Vaira M; Cioppa T; D'Amico S; de Marco G; D'Alessandro M; Fiorentini G; De Simone M
    In Vivo; 2010; 24(1):79-84. PubMed ID: 20133981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy in patients with peritoneal hepatocellular carcinoma.
    Tabrizian P; Franssen B; Jibara G; Sweeney R; Sarpel U; Schwartz M; Labow D
    J Surg Oncol; 2014 Dec; 110(7):786-90. PubMed ID: 25091997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal and gastrointestinal origin shows acceptable morbidity and high survival.
    Hagendoorn J; van Lammeren G; Boerma D; van der Beek E; Wiezer MJ; van Ramshorst B
    Eur J Surg Oncol; 2009 Aug; 35(8):833-7. PubMed ID: 19019619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of peritoneal carcinomatosis from ovarian cancer by surgical cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC).
    Robella M; Vaira M; Marsanic P; Mellano A; Borsano A; Cinquegrana A; Sottile A; De Simone M
    Minerva Chir; 2014 Feb; 69(1):27-35. PubMed ID: 24675244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of peritoneal carcinomatosis from colonic cancer by cytoreduction, peritonectomy and HIPEC: preliminary results in highly selected patients.
    Robella M; Vaira M; Marsanic P; Mellano A; Cinquegrana A; Sottile A; De Simone M
    Minerva Chir; 2013 Dec; 68(6):551-8. PubMed ID: 24193287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of gastrointestinal cancers with peritoneal metastases: Progress toward a new standard of care.
    Sugarbaker PH
    Cancer Treat Rev; 2016 Jul; 48():42-9. PubMed ID: 27347669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Results of two bi-institutional prospective studies using intraperitoneal oxaliplatin with or without irinotecan during HIPEC after cytoreductive surgery for colorectal carcinomatosis.
    Quenet F; Goéré D; Mehta SS; Roca L; Dumont F; Hessissen M; Saint-Aubert B; Elias D
    Ann Surg; 2011 Aug; 254(2):294-301. PubMed ID: 21772129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peritoneal cancer patients not suitable for cytoreductive surgery and HIPEC during explorative surgery: risk factors, treatment options, and prognosis.
    van Oudheusden TR; Braam HJ; Luyer MD; Wiezer MJ; van Ramshorst B; Nienhuijs SW; de Hingh IH
    Ann Surg Oncol; 2015 Apr; 22(4):1236-42. PubMed ID: 25319584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Peritoneal carcinomatosis. Surgical treatment, including hyperthermal intraperitoneal chemotherapy].
    Glockzin G; Ghali N; Lang SA; Agha A; Schlitt HJ; Piso P
    Chirurg; 2007 Dec; 78(12):1100, 1102-6, 1108-10. PubMed ID: 17992490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. (18)F-FDG-PET/CT to select patients with peritoneal carcinomatosis for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    Pfannenberg C; Königsrainer I; Aschoff P; Oksüz MO; Zieker D; Beckert S; Symons S; Nieselt K; Glatzle J; Weyhern CV; Brücher BL; Claussen CD; Königsrainer A
    Ann Surg Oncol; 2009 May; 16(5):1295-303. PubMed ID: 19252950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.